REQUEST A DEMO
Total
USD $0.00
Search more companies

Jonnex-Farma SIA (Latvia)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Jonnex-Farma SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Jonnex-Farma SIA is an enterprise in Latvia, with the main office in Riga. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on October 25, 2002. There are currently 5 (estimated) people employed by Jonnex-Farma SIA. From the latest financial highlights, Jonnex-Farma SIA reported a net sales revenue increase of 16.02% in 2024. Its’ total assets recorded a growth of 51.23%. Jonnex-Farma SIA’s net profit margin decreased by 5.23% in 2024.

Headquarters
Stabu iela 472
Riga; Riga; Postal Code: 1011

Contact Details: Purchase the Jonnex-Farma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Jonnex-Farma SIA report to view the information.
Registered Capital:
Purchase the Jonnex-Farma SIA report to view the information.
Financial Auditors:
Purchase the Jonnex-Farma SIA report to view the information.
Incorporation Date:
October 25, 2002
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Jonnex-Farma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
16.02%
Total operating revenue
15.64%
Operating profit (EBIT)
5.41%
EBITDA
5.41%
Net Profit (Loss) for the Period
7.21%
Total Assets
51.23%
Total Equity
50.94%
Operating Profit Margin (ROS)
-6.3%
Net Profit Margin
-5.23%
Return on Equity (ROE)
-13.77%
Quick Ratio
-1.94%
Cash Ratio
-19.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?